Jun 23, 2014 2:00pm EDT OPKO Announces Positive Interim Six-Month Lagova™ (hGH-CTP) Phase 2 Data in Pediatric Growth Hormone Deficiency Disorder
Jun 19, 2014 1:21pm EDT OPKO to Hold Conference Call to Discuss Six Month Data from Phase 2 hGH-CTP Trial
May 20, 2014 10:26am EDT Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at the 2014 ICE/ENDO Meeting
May 19, 2014 3:04pm EDT OPKO Presents 4Kscore™ Test Clinical Study at the American Urological Association Plenary Session
May 12, 2014 11:20am EDT OPKO Licensee TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant